Semanteon Capital Management, LP Amicus Therapeutics, Inc. Transaction History
Semanteon Capital Management, LP
- $186 Billion
- Q4 2024
A detailed history of Semanteon Capital Management, LP transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Semanteon Capital Management, LP holds 149,156 shares of FOLD stock, worth $1.34 Million. This represents 0.75% of its overall portfolio holdings.
Number of Shares
149,156
Previous 105,868
40.89%
Holding current value
$1.34 Million
Previous $1.13 Billion
24.27%
% of portfolio
0.75%
Previous 0.77%
Shares
2 transactions
Others Institutions Holding FOLD
# of Institutions
312Shares Held
311MCall Options Held
467KPut Options Held
515K-
Vanguard Group Inc Valley Forge, PA29.3MShares$263 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA28.5MShares$256 Million0.05% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$219 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY24.2MShares$218 Million7.62% of portfolio
-
Avoro Capital Advisors LLC New York, NY23.2MShares$208 Million3.18% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.52B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...